Primary |
Growth Hormone Deficiency |
31.3% |
Product Used For Unknown Indication |
16.6% |
Drug Use For Unknown Indication |
12.1% |
Hypopituitarism |
11.2% |
Small For Dates Baby |
5.8% |
Body Height Below Normal |
4.9% |
Renal Failure |
2.9% |
Turner's Syndrome |
2.6% |
Growth Retardation |
2.4% |
Hypothyroidism |
1.3% |
Off Label Use |
1.3% |
Foetal Growth Restriction |
1.0% |
Hypersensitivity |
1.0% |
Influenza |
1.0% |
Respiratory Disorder |
1.0% |
Supplementation Therapy |
0.8% |
Abnormal Behaviour |
0.7% |
Diabetes Insipidus |
0.7% |
Emotional Disorder Of Childhood |
0.7% |
Juvenile Arthritis |
0.7% |
|
Osteochondrosis |
9.3% |
Convulsion |
8.8% |
Vomiting |
8.8% |
Scoliosis |
7.1% |
Pituitary Tumour Benign |
6.6% |
Condition Aggravated |
6.0% |
Astrocytoma |
5.5% |
Tenosynovitis Stenosans |
4.9% |
Craniopharyngioma |
3.8% |
Death |
3.8% |
Enchondroma |
3.8% |
Neoplasm Malignant |
3.8% |
Papilloedema |
3.8% |
Sleep Apnoea Syndrome |
3.8% |
Arthritis |
3.3% |
Bone Sarcoma |
3.3% |
Neoplasm Progression |
3.3% |
Pyrexia |
3.3% |
Thyroid Cancer |
3.3% |
Viith Nerve Paralysis |
3.3% |
|
Secondary |
Growth Hormone Deficiency |
31.8% |
Hypopituitarism |
12.3% |
Product Used For Unknown Indication |
11.5% |
Small For Dates Baby |
7.0% |
Drug Use For Unknown Indication |
6.8% |
Hypersensitivity |
6.3% |
Attention Deficit/hyperactivity Disorder |
6.0% |
Growth Retardation |
3.0% |
Respiratory Disorder |
3.0% |
Body Height Below Normal |
2.5% |
Foetal Growth Retardation |
2.0% |
Hypothyroidism |
1.3% |
Influenza |
1.3% |
Silver-russell Syndrome |
1.3% |
Cardiac Failure Congestive |
1.0% |
Diabetes Insipidus |
0.8% |
Juvenile Arthritis |
0.8% |
Turner's Syndrome |
0.8% |
Back Pain |
0.5% |
Cataract |
0.5% |
|
Cerebellar Atrophy |
10.6% |
Vomiting |
10.6% |
Astrocytoma |
8.8% |
Breast Cancer |
8.0% |
Iga Nephropathy |
8.0% |
Visual Acuity Reduced |
8.0% |
Germ Cell Cancer |
5.3% |
Convulsion |
4.4% |
Upper Respiratory Tract Inflammation |
4.4% |
Ewing's Sarcoma |
3.5% |
Macrogenia |
3.5% |
Osteochondrosis |
3.5% |
Acth-producing Pituitary Tumour |
2.7% |
Brain Neoplasm |
2.7% |
Enchondroma |
2.7% |
Hair Follicle Tumour Benign |
2.7% |
Incorrect Dose Administered |
2.7% |
Pituitary Tumour Benign |
2.7% |
Pulmonary Embolism |
2.7% |
Sleep Apnoea Syndrome |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
32.8% |
Convulsion |
6.9% |
Drug Use For Unknown Indication |
6.9% |
Hypopituitarism |
6.9% |
Asthma |
6.1% |
Pain |
6.1% |
Renal Failure Chronic |
5.3% |
Osteoporosis |
3.8% |
Gastrooesophageal Reflux Disease |
3.1% |
Juvenile Arthritis |
3.1% |
Blood Cholesterol |
2.3% |
Cough |
2.3% |
Growth Hormone Deficiency |
2.3% |
Hypothyroidism |
2.3% |
Polyarthritis |
2.3% |
Abdominal Pain |
1.5% |
Addison's Disease |
1.5% |
Crohn's Disease |
1.5% |
Hiv Test Positive |
1.5% |
Hypersensitivity |
1.5% |
|
Anti-erythropoietin Antibody Positive |
8.8% |
White Blood Cell Count Decreased |
8.8% |
Anaemia |
5.9% |
Anorexia Nervosa |
5.9% |
Gait Disturbance |
5.9% |
Hypersensitivity |
5.9% |
Increased Appetite |
5.9% |
Pancytopenia |
5.9% |
Road Traffic Accident |
5.9% |
Teeth Brittle |
5.9% |
Therapeutic Response Decreased |
5.9% |
Wrong Technique In Drug Usage Process |
5.9% |
Abdominal Pain |
2.9% |
Abdominal Pain Lower |
2.9% |
Asthma |
2.9% |
Blood Creatinine Increased |
2.9% |
Blood Pressure Inadequately Controlled |
2.9% |
Bone Disorder |
2.9% |
Chest Pain |
2.9% |
Cholelithiasis |
2.9% |
|